Forte Biosciences, Inc. – NASDAQ:FBRX
Forte Biosciences stock price today
$11.75
-11.17
-48.73%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 6 hours
Forte Biosciences stock price monthly change
+4099.34%
month
Forte Biosciences stock price quarterly change
+4099.34%
quarter
Forte Biosciences stock price yearly change
+3035.43%
year
Forte Biosciences key metrics
Market Cap | 26.43M |
Enterprise value | N/A |
P/E | -1.43 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.48 |
PEG ratio | -0.02 |
EPS | -1 |
Revenue | N/A |
EBITDA | -33.42M |
Income | -32.14M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeForte Biosciences stock price history
Forte Biosciences stock forecast
Forte Biosciences financial statements
| Jun 2023 | 0 | -8.89M | |
|---|---|---|---|
| Sep 2023 | 0 | -9.95M | |
| Dec 2023 | 6K | -5.87M | -97866.67% |
| Mar 2024 | 0 | -7.42M |
| Mar 2024 | 0 | -7.42M | |
|---|---|---|---|
| Sep 2025 | 6K | -2.54M | -42390.95% |
| Oct 2025 | 0 | -3.68M | |
| Dec 2025 | 0 | -3.68M |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 31184000 | 6.3M | 20.2% |
|---|---|---|---|
| Sep 2023 | 47879000 | 7.47M | 15.6% |
| Dec 2023 | 38980000 | 3.66M | 9.4% |
| Mar 2024 | 32017000 | 3.33M | 10.41% |
| Jun 2023 | -5.47M | -9.96M | -24K |
|---|---|---|---|
| Sep 2023 | -9.05M | 10.02M | 24.77M |
| Dec 2023 | -8.96M | -16K | -75K |
| Mar 2024 | -6.66M | -6K | -8K |
Forte Biosciences alternative data
| Aug 2023 | 7 |
|---|---|
| Sep 2023 | 7 |
| Oct 2023 | 7 |
| Nov 2023 | 7 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 9 |
| Apr 2024 | 9 |
| May 2024 | 9 |
| Jun 2024 | 9 |
| Jul 2024 | 11 |
Forte Biosciences other data
12.63%
-7.46%
of FBRX is owned by hedge funds
14
-16
2.19M
-1.60M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 111499 | 0 |
| Nov 2024 | 22514 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Common Stock | 22,514 | $5.55 | $124,998 | ||
Option | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Common Stock | 375 | N/A | N/A | ||
Option | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Restricted Stock Units | 375 | N/A | N/A | ||
Option | WAGNER PAUL A. director, officer.. | Common Stock | 1,250 | N/A | N/A | ||
Option | WAGNER PAUL A. director, officer.. | Restricted Stock Units | 1,250 | N/A | N/A | ||
Option | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Common Stock | 9,375 | N/A | N/A | ||
Option | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Restricted Stock Units | 9,375 | N/A | N/A | ||
Option | WAGNER PAUL A. director, officer.. | Common Stock | 31,250 | N/A | N/A | ||
Option | WAGNER PAUL A. director, officer.. | Restricted Stock Units | 31,250 | N/A | N/A | ||
Option | RILEY ANTONY A officer: CHIEF FINANCIAL OFFICER | Common Stock | 9,375 | N/A | N/A |
| Patent |
|---|
Application Filling date: 2 May 2019 Issue date: 14 Nov 2019 |
Application Filling date: 17 Apr 2019 Issue date: 24 Oct 2019 |
| Quarter | Transcript |
|---|---|
| Q1 2021 11 May 2021 | Q1 2021 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Paul A. Wagner Ph.D. (1970) Pres, Chief Executive Officer & Chairman | $776,920 |
Mr. Antony A. Riley CPA (1967) Chief Financial Officer | $450,660 |
-
What's the price of Forte Biosciences stock today?
One share of Forte Biosciences stock can currently be purchased for approximately $11.75.
-
When is Forte Biosciences's next earnings date?
Unfortunately, Forte Biosciences's (FBRX) next earnings date is currently unknown.
-
Does Forte Biosciences pay dividends?
No, Forte Biosciences does not pay dividends.
-
How much money does Forte Biosciences make?
Forte Biosciences has a market capitalization of 26.43M.
-
What is Forte Biosciences's stock symbol?
Forte Biosciences, Inc. is traded on the NASDAQ under the ticker symbol "FBRX".
-
What is Forte Biosciences's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Forte Biosciences?
Shares of Forte Biosciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Forte Biosciences's key executives?
Forte Biosciences's management team includes the following people:
- Dr. Paul A. Wagner Ph.D. Pres, Chief Executive Officer & Chairman(age: 55, pay: $776,920)
- Mr. Antony A. Riley CPA Chief Financial Officer(age: 58, pay: $450,660)
-
How many employees does Forte Biosciences have?
As Jul 2024, Forte Biosciences employs 11 workers, which is 22% more then previous month and 22% more then previous quarter.
-
When Forte Biosciences went public?
Forte Biosciences, Inc. is publicly traded company for more then 8 years since IPO on 13 Apr 2017.
-
What is Forte Biosciences's official website?
The official website for Forte Biosciences is fortebiorx.com.
-
Where are Forte Biosciences's headquarters?
Forte Biosciences is headquartered at 3060 Pegasus Park Drive, Dallas, TX.
-
How can i contact Forte Biosciences?
Forte Biosciences's mailing address is 3060 Pegasus Park Drive, Dallas, TX and company can be reached via phone at +31 6186994.
Forte Biosciences company profile:
Forte Biosciences, Inc.
fortebiorx.comExchange:
NASDAQ
Full time employees:
11
Industry:
Biotechnology
Sector:
Healthcare
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
3060 Pegasus Park Drive
Dallas, TX 75247
Dallas, TX 75247
CIK: 0001419041
ISIN: US34962G1094
CUSIP: 34962G109
